SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Rafael’s Spyder enters Czech service as Prague considers more Israeli air defense systems

Netanyahu calls off Elon Musk meeting as U.S. trip is sharply shortened

Anthropic considers new model to counter OpenAI’s latest AI push

Google’s Gemini hacked real companies during a cyber test linked to Israeli startup Irregular

Buzz

Most popular

Daily

Weekly

1

“Our next milestone will be a billion-dollar valuation”: MIND triples valuation to $300 million with $72 million Series B

2

Serbia opens Israeli drone factory as defense ties with Elbit deepen

3

The man who helped build Palo Alto’s Cortex is leaving the company

4

Netanyahu calls off Elon Musk meeting as U.S. trip is sharply shortened

5

Keewano raises $12 million Seed to build a new database for the age of AI agents

89Bio

3 stories about 89Bio

Roche strikes $3.5 billion deal for U.S.-Israeli biotech 89bio

Founded in 2018 from Teva’s pipeline, the biotech firm is set to become a centerpiece in Roche’s obesity strategy.

Teva-Linked Biotech Company 89Bio Files for Nasdaq IPO

Israel and San Francisco-based 89Bio raised a $60 million series A in October 2018

מייקל היידן מחקר ו פיתוח טבע

Former Teva Executives Raise $60 Million for Metabolic Disorders Venture

28.10.18|Lilach Baumer

The company’s pipeline of biologic and small molecule drug candidates was acquired from Teva